Cargando…
Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye
Posterior eye diseases, such as age-related macular degeneration and diabetic retinopathy, are difficult to treat due to ineffective drug delivery to affected areas. Intravitreal injection is the primary method for posterior eye drug delivery; however, it is usually accompanied by complications. The...
Autores principales: | Tsai, Cheng-Han, Hoang, Le Ngoc, Lin, Chun Che, Pan, Liang-Chen, Wu, Chiao-Li, Lin, I-Chan, Wang, Peng-Yuan, Tseng, Ching-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228085/ https://www.ncbi.nlm.nih.gov/pubmed/35745825 http://dx.doi.org/10.3390/pharmaceutics14061253 |
Ejemplares similares
-
Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery
por: Silva, Beatriz, et al.
Publicado: (2022) -
Administering a subconjunctival injection
por: Stevens, Sue
Publicado: (2009) -
Topical Drug Delivery to the Posterior Segment of the Eye
por: Löscher, Marina, et al.
Publicado: (2022) -
Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety
por: Liu, Guei-Sheung, et al.
Publicado: (2015) -
Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
por: Jiang, Xiaodan, et al.
Publicado: (2015)